Trandolapril
Back to searchMolecule Structure
Scientific Name
Trandolapril
Description of the Drug
Trandolapril is a prodrug of an ACE inhibitor used to treat hypertension, congestive heart failure, and to improve survival following a myocardial infarction.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00519
http://www.drugbank.ca/drugs/DB00519
Brand Name(s)
Gopten, Mavik, Odrik, Trandolapril
Company Owner(s)
Epic Pharma Llc, Cipla Ltd, Glenmark Generics Ltd, Invagen Pharmaceuticals Inc, Watson Laboratories Inc, Aurobindo Pharma Ltd, Abbvie Inc, Dr Reddys Laboratories Ltd, Mylan Pharmaceuticals Inc, Teva Pharmaceuticals Usa
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Angiotensin-converting enzyme | SINGLE PROTEIN | INHIBITOR | CHEMBL1808 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL16610 | |
| PharmGKB | PA451737 | |
| Human Metabolome Database | HMDB0014660 | |
| DrugBank | DB00519 | |
| PubChem: Thomson Pharma | 14929957 | 14807551 |
| PubChem | 5484727 | 37888437 |
| Nikkaji | J33.158I | |
| BindingDB | 50369775 | |
| EPA CompTox Dashboard | DTXSID2023692 | |
| DrugCentral | 2712 | |
| Brenda | 25040 | |
| ChemicalBook | CB8682356 | |
| Guide to Pharmacology | 6453 | |
| rxnorm | MAVIK | TRANDOLAPRIL |
| PubChem: Drugs of the Future | 12013675 | |
| ChEBI | 9649 | |
| ZINC | ZINC000001853205 |
